[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: Clinical outcomes and patterns of failure

This publication has 22 references indexed in Scilit:

• Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: Report of the radiation therapy oncology group 98–03 protocol
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Prediction of Pathology and Survival by FDG PET in Gliomas
  Journal of Neuro-Oncology, 2003
• A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM)
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal Radiotherapy
  Journal of Clinical Oncology, 2002
• Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide
  Journal of Clinical Oncology, 2002
• Corpus callosum involvement as a prognostic factor for patients with high-grade astrocytoma
  International Journal of Radiation Oncology*Biology*Physics, 1997
• 18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma
  Cancer, 1997
• Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography-guided stereotactic biopsy
  Cancer, 1996
• Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
  Radiology, 1995
• Prediction of survival in glioma patients by means of positron emission tomography
  Journal of Neurosurgery, 1985